Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen
- 12 March 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 75 (6) , 1001-1009
- https://doi.org/10.1189/jlb.0803391
Abstract
Eosinophil degranulation is thought to play a pivotal role in the pathogenesis of allergic disorders. Although mouse models of allergic disorders have been used extensively to identify the contribution of eosinophils to disease, ultrastructural evidence of active granule disassembly has not been reported. In this investigation, we characterized the degree of eosinophil activation in the bone marrow, blood, lung tissue, and airways lumen [bronchoalveolar lavage fluid (BALF)] of ovalbumin-sensitized and aero-challenged wild-type and interleukin-5 transgenic mice. Degranulation was most prominent in and primarily compartmentalized to the airways lumen. Eosinophils released granule proteins by the process of piecemeal degranulation (PMD). Accordingly, recruitment and activation of eosinophils in the lung correlated with the detection of cell-free eosinophil peroxidase in BALF and with the induction of airways hyper-reactivity. As in previous studies with human eosinophils, degranulation of isolated mouse cells did not occur until after adherence to extracellular matrix. However, higher concentrations of exogenous stimuli appear to be required to trigger adherence and degranulation (piecemeal) of mouse eosinophils when compared with values reported for studies of human eosinophils. Thus, mouse eosinophils undergo PMD during allergic inflammation, and in turn, this process may contribute to pathogenesis. However, the degranulation process in the allergic lung of mice is primarily compartmentalized to the airway lumen. Understanding the mechanism of eosinophil degranulation in the airway lumen may provide important insights into how this process occurs in human respiratory diseases.Keywords
Funding Information
- NHMRC Programe
- Human Frontiers Science Foundation
- NIH
This publication has 41 references indexed in Scilit:
- Cytolysis and piecemeal degranulation as distinct modes of activation of airway mucosal eosinophilsJournal of Allergy and Clinical Immunology, 1998
- A microtiter assay for activation of eosinophils.Allergy, 1998
- Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.The Journal of Experimental Medicine, 1996
- Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.The Journal of Experimental Medicine, 1996
- Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation.Journal of Clinical Investigation, 1995
- Eosinophil inflammation of the nasal mucosa in allergic and non‐allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serumClinical and Experimental Allergy, 1994
- Ultrastructural Identification of Exocytosis of Granules from Human Gut Eosinophils in vivoInternational Archives of Allergy and Immunology, 1993
- Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitroJournal of Allergy and Clinical Immunology, 1990
- Intracellular application of guanosine-5'-O-(3-thiotriphosphate) induces exocytotic granule fusion in guinea pig eosinophils.The Journal of Experimental Medicine, 1990
- IDENTIFICATION BY IMMUNOFLUORESCENCE OF EOSINOPHIL GRANULE MAJOR BASIC PROTEIN IN LUNG TISSUES OF PATIENTS WITH BRONCHIAL ASTHMAThe Lancet, 1982